XML 119 R83.htm IDEA: XBRL DOCUMENT v3.6.0.2
Investment in Inex Bio, Inc - Additional Information (Detail) - USD ($)
1 Months Ended 2 Months Ended 12 Months Ended
Mar. 30, 2015
Apr. 30, 2015
May 31, 2012
Apr. 30, 2012
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Jun. 30, 2013
Asset Purchase [Line Items]                    
Number of shares acquired during period     57,000              
Stock issued during period, value, acquisitions     $ 200,000              
Outstanding shares acquired, percentage     22.20%              
Percentage of fully diluted shares acquired     17.40%              
Proceeds from exercise of warrants           $ 52,000 $ 7,348,000 $ 0    
Stock-based compensation expense           73,852,000 211,221,000 789,000    
Common Class A                    
Asset Purchase [Line Items]                    
Stock price of warrants                   $ 2.44
Stock-based compensation expense               200,000    
Inex Bio Holdings, LLC                    
Asset Purchase [Line Items]                    
Payments to acquire business           6,500,000        
Stock price of warrants $ 10.72                  
Term of warrants after closing date of the purchase agreement 15 days                  
Expected volatility rate 80.00%                  
Issuance of warrants in Inex Bio acquisition           22,747,000        
Stock-based compensation expense           22,700,000        
Cash based compensation           $ 5,400,000        
Inex Bio Holdings, LLC | Common Class A                    
Asset Purchase [Line Items]                    
Warrants issued to acquire shares           2,609,520        
Common stock exercise price           $ 2.00        
Proceeds from exercise of warrants   $ 5,200,000                
Other Owner Of Inex Bio Inc                    
Asset Purchase [Line Items]                    
Payments to acquire business $ 1,500,000                  
Stock price of warrants $ 10.72                  
Term of warrants after closing date of the purchase agreement 15 days                  
Expected volatility rate 80.00%                  
Issuance of warrants in Inex Bio acquisition           $ 5,170,000        
Other Owner Of Inex Bio Inc | Common Class A                    
Asset Purchase [Line Items]                    
Warrants issued to acquire shares 593,072                  
Common stock exercise price $ 2.00                  
Proceeds from exercise of warrants   $ 1,200,000                
Inex Bio                    
Asset Purchase [Line Items]                    
Intangible assets amortizes period           4 years        
Cambridge Equities, L.P | Inex Bio Holdings, LLC                    
Asset Purchase [Line Items]                    
Ownership percentage of third party business         50.00%          
Eragon Ventures, LLC                    
Asset Purchase [Line Items]                    
Number of shares acquired during period         220,000          
Ownership percentage of third party business         50.00%          
Percentage shares acquired         67.30%          
Payments to acquire business         $ 1,100,000          
Inex license agreement                    
Asset Purchase [Line Items]                    
Milestone payment amount             $ 0 $ 0 $ 0  
Percentage of royalty on net sales       5.00%            
Up front fee | Inex license agreement                    
Asset Purchase [Line Items]                    
License fees received       $ 300,000            
Maximum | Inex license agreement                    
Asset Purchase [Line Items]                    
Milestone payment amount       $ 800,000